W. Thomas Grant II - Nov 14, 2023 Form 4 Insider Report for SelectQuote, Inc. (SLQT)

Role: Director
Signature: /s/ Daniel A. Boulware, Attorney-in-Fact
Stock symbol: SLQT
Transactions as of: Nov 14, 2023
Transactions value $: $0
Form type: 4
Date filed: 11/16/2023, 07:44 PM
Previous filing: Sep 18, 2023
Next filing: Nov 14, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SLQT	Common Stock, par value $0.01 per share	Options Exercise	$0	+203K	+8.49%	$0.00	2.6M	Nov 14, 2023	Direct
holding	SLQT	Common Stock, par value $0.01 per share						1.35M	Nov 14, 2023	By Self as Trustee for the W. Thomas Grant II Family Irrevocable Trust
holding	SLQT	Common Stock, par value $0.01 per share						356K	Nov 14, 2023	By Fidelity IRA
holding	SLQT	Common Stock, par value $0.01 per share						220K	Nov 14, 2023	By Frances D. Grant Trust	F1
holding	SLQT	Common Stock, par value $0.01 per share						35.6K	Nov 14, 2023	By Mainstar Trust IRA

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SLQT	Restricted Stock Units	Options Exercise	$0	-203K	-100%	$0.00^*	0	Nov 14, 2023	Common Stock, par value $0.01 per share	203K		Direct	F2, F3, F4
transaction	SLQT	Restricted Stock Units	Award	$0	+94.9K		$0.00	94.9K	Nov 14, 2023	Common Stock, par value $0.01 per share	94.9K		Direct	F2, F3, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares held indirectly by Mr. Grant in his capacity as Trustee of family trust.
F2	Represents restricted stock units of SelectQuote, Inc. (the "Company") granted to the recipient pursuant to the Company's 2020 Omnibus Incentive Plan.
F3	Each restricted stock unit represents a contingent right to receive one share of the Company's common stock, par value $0.01 per share.
F4	The award vested in full on the transaction date reported on this line.
F5	The award vests in full on the date of the Company's 2024 annual meeting of stockholders (the "Vesting Date"), subject to the recipient's continued service on the Board of Directors as of the Vesting Date.